CD9:PA:PA-Amundi MSCI Europe High Dividend UCITS (EUR)

ETF | Others |

Last Closing

USD 200.9

Change

+0.50 (+0.25)%

Market Cap

USD 0.15B

Volume

153.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.61 (+1.30%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.80 (+0.14%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.07 (+0.02%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.26%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.87 (+1.10%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.10 (+0.02%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.10 (+0.31%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.07 (+0.12%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.16 (-2.18%)

USD 5.25B

ETFs Containing CD9:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.32% 81% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.32% 80% B- 72% C
Trailing 12 Months  
Capital Gain 21.17% 85% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.17% 84% B 82% B
Trailing 5 Years  
Capital Gain 62.09% 61% D- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.09% 58% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.12% 71% C- 72% C
Dividend Return 13.12% 65% D 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.23% 74% C 87% B+
Risk Adjusted Return 159.46% 94% A 100% F
Market Capitalization 0.15B 36% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.